Tokyo - Delayed Quote JPY

Kitanotatsujin Corporation (2930.T)

146.00
+2.00
+(1.39%)
As of 10:48:57 AM GMT+9. Market Open.
Loading Chart for 2930.T
  • Previous Close 144.00
  • Open 146.00
  • Bid 145.00 x --
  • Ask 146.00 x --
  • Day's Range 145.00 - 147.00
  • 52 Week Range 132.00 - 189.00
  • Volume 240,400
  • Avg. Volume 674,528
  • Market Cap (intraday) 20.333B
  • Beta (5Y Monthly) 1.44
  • PE Ratio (TTM) 16.84
  • EPS (TTM) 8.67
  • Earnings Date Jul 10, 2025 - Jul 14, 2025
  • Forward Dividend & Yield 4.40 (3.08%)
  • Ex-Dividend Date Feb 27, 2025
  • 1y Target Est --

Kitanotatsujin Corporation plans, develops, manufactures, and sells health foods, cosmetics, and miscellaneous goods in Japan. It offers health foods and beauty products under the J North Farm brand. The company sell its products through its e-commerce website. Kitanotatsujin Corporation was founded in 2000 and is headquartered in Tokyo, Japan.

www.kitanotatsujin.com

--

Full Time Employees

February 28

Fiscal Year Ends

Recent News: 2930.T

View More

Performance Overview: 2930.T

Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

2930.T
2.67%
Nikkei 225 (^N225)
5.79%

1-Year Return

2930.T
17.85%
Nikkei 225 (^N225)
1.68%

3-Year Return

2930.T
13.18%
Nikkei 225 (^N225)
45.97%

5-Year Return

2930.T
70.84%
Nikkei 225 (^N225)
84.55%

Compare To: 2930.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2930.T

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    20.05B

  • Enterprise Value

    14.36B

  • Trailing P/E

    16.63

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.70

  • Price/Book (mrq)

    2.55

  • Enterprise Value/Revenue

    1.21

  • Enterprise Value/EBITDA

    7.71

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.08%

  • Return on Assets (ttm)

    19.50%

  • Return on Equity (ttm)

    25.93%

  • Revenue (ttm)

    9.61B

  • Net Income Avi to Common (ttm)

    1.35B

  • Diluted EPS (ttm)

    8.67

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.7B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    1.47B

Research Analysis: 2930.T

View More

Company Insights: 2930.T

Research Reports: 2930.T

View More

People Also Watch